| Primary |
| Hepatic Neoplasm Malignant |
23.1% |
| Hypertension |
14.5% |
| Prophylaxis |
10.4% |
| Diabetes Mellitus |
5.5% |
| Diarrhoea |
4.9% |
| Pain |
4.2% |
| Abdominal Pain |
3.9% |
| Surgery |
3.5% |
| Renal Cell Carcinoma |
3.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.9% |
| Medical Diet |
2.8% |
| Constipation |
2.7% |
| Nausea |
2.6% |
| Hepatocellular Carcinoma |
2.6% |
| Thyroid Cancer |
2.6% |
| Hepatitis B |
2.2% |
| Insomnia |
2.2% |
| Gastric Cancer |
2.1% |
| Supplementation Therapy |
2.1% |
| Ascites |
2.1% |
|
| Hepatic Encephalopathy |
9.5% |
| Ascites |
8.4% |
| Diarrhoea |
8.4% |
| Hepatic Failure |
7.7% |
| Pulmonary Embolism |
6.6% |
| Death |
5.5% |
| Vomiting |
5.5% |
| Fatigue |
5.0% |
| Pyrexia |
5.0% |
| Hypertension |
4.5% |
| Decreased Appetite |
4.3% |
| Rash |
3.9% |
| Abdominal Pain |
3.6% |
| Asthenia |
3.4% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Deep Vein Thrombosis |
3.2% |
| Skin Ulcer |
3.2% |
| Cerebral Ischaemia |
3.0% |
| Cerebrovascular Accident |
3.0% |
| Left Ventricular Dysfunction |
3.0% |
|
| Secondary |
| Hepatic Neoplasm Malignant |
15.1% |
| Hypertension |
10.2% |
| Prophylaxis |
9.6% |
| Surgery |
8.9% |
| Hepatocellular Carcinoma |
8.3% |
| Abdominal Pain |
5.0% |
| Medical Diet |
4.6% |
| Diarrhoea |
4.4% |
| Thyroid Cancer |
4.3% |
| Diabetes Mellitus |
3.9% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.1% |
| Decreased Appetite |
3.1% |
| Nausea |
2.9% |
| Hepatitis B |
2.8% |
| Computerised Tomogram |
2.5% |
| Oesophagitis |
2.3% |
| Anxiety |
2.3% |
| Insomnia |
2.3% |
| Gastric Ulcer |
2.3% |
| Abdominal Pain Upper |
2.1% |
|
| Diarrhoea |
12.5% |
| Arthralgia |
7.4% |
| Retinal Vein Occlusion |
7.4% |
| Hepatic Encephalopathy |
6.9% |
| Left Ventricular Dysfunction |
6.0% |
| Abdominal Pain |
5.5% |
| Lung Disorder |
5.4% |
| Duodenal Ulcer |
4.4% |
| Hypertension |
4.4% |
| Hypokalaemia |
4.1% |
| Hepatic Failure |
3.9% |
| Respiratory Failure |
3.8% |
| Upper Gastrointestinal Haemorrhage |
3.8% |
| Abdominal Pain Upper |
3.6% |
| Ascites |
3.6% |
| Myopathy |
3.6% |
| Retinal Vascular Disorder |
3.6% |
| Retinal Vascular Thrombosis |
3.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Staphylococcal Infection |
3.2% |
|
| Interacting |
| Acute Myeloid Leukemia |
53.3% |
| Antifungal Prophylaxis |
20.0% |
| Antiretroviral Therapy |
13.3% |
| Hepatocellular Carcinoma |
13.3% |
|
| Viral Infection |
50.0% |
| Hypertension |
25.0% |
| Inhibitory Drug Interaction |
25.0% |
|
